Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Issued: 2023-2025

Historic Shares Issued for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $48.3 million.

  • CG Oncology's Shares Issued was N/A to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.1 million, marking a year-over-year change of. This contributed to the annual value of $406.4 million for FY2024, which is 19420.17% up from last year.
  • CG Oncology's Shares Issued amounted to $48.3 million in Q3 2025, which was up 254,110.53% from $19,000 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Shares Issued registered a high of $406.4 million during Q1 2024, and its lowest value of $19,000 during Q2 2025.
  • For the 3-year period, CG Oncology's Shares Issued averaged around $75.6 million, with its median value being $682,000 (2025).
  • As far as peak fluctuations go, CG Oncology's Shares Issued soared by 597,561.76% in 2024, and later crashed by 99.83% in 2025.
  • Over the past 3 years, CG Oncology's Shares Issued (Quarterly) stood at $262,000 in 2023, then spiked by 85,052.67% to $223.1 million in 2024, then plummeted by 99.83% to $48.3 million in 2025.
  • Its Shares Issued was $48.3 million in Q3 2025, compared to $19,000 in Q2 2025 and $682,000 in Q1 2025.